CiVi Biopharma Overview

  • Year Founded
  • 2017

Year Founded

  • Status
  • Private

  • Employees
  • 13

Employees

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 2

CiVi Biopharma General Information

Description

Developer of novel therapies designed to treat cardiovascular and orphan diseases. The company develops novel cardiovascular and metabolic treatments that bring meaningful therapeutic value to patients with unsatisfied medical needs in cardiovascular and rare diseases, enabling physicians to treat critical diseases such as cardiovascular and orphan diseases.

Contact Information

Website
www.civibio.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 5425 Wisconsin Avenue
  • 6th Floor
  • Chevy Chase, MD 20815
  • United States
+1 (301)
Primary Industry
Drug Discovery
Vertical(s)
Life Sciences
Corporate Office
  • 5425 Wisconsin Avenue
  • 6th Floor
  • Chevy Chase, MD 20815
  • United States
+1 (301)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

CiVi Biopharma Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Secondary Transaction - Private 01-May-2026 Completed Clinical Trials - Phase 3
4. Early Stage VC 15-Dec-2020 Completed Clinical Trials - Phase 3
3. Early Stage VC 25-May-2018 Completed Clinical Trials - Phase 1
2. Early Stage VC (Series A) 05-Jan-2017 $40M $45M Completed Clinical Trials - Phase 1
1. Early Stage VC $5M $5M Completed Startup
To view CiVi Biopharma’s complete valuation and funding history, request access »

CiVi Biopharma Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate ($) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series A
Series A1
To view CiVi Biopharma’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

CiVi Biopharma Patents

  • 21

    Total Documents Applications and Grants

  • Total Patents Families

  • 8

    Granted

  • 10

    Pending

  • Expiring in next 12 mo

CiVi Biopharma Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2022261982-A1 Oral delivery of oligonucleotides Active 22-Apr-2021
AU-2022261982-A2 Oral delivery of oligonucleotides Active 22-Apr-2021
AU-2022261982-A9 Oral delivery of oligonucleotides Active 22-Apr-2021
AU-2022261982-B2 Oral delivery of oligonucleotides Active 22-Apr-2021
CA-3216091-A1 Oral delivery of oligonucleotides Pending 22-Apr-2021 C12N15/111
To view CiVi Biopharma’s complete patent history, request access »

CiVi Biopharma Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

CiVi Biopharma Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
RA Capital Management Asset Manager Minority
Tang Capital Partners Corporation Minority
To view CiVi Biopharma’s complete investors history, request access »

Ready to get started?

Request a free trial

CiVi Biopharma FAQs

  • When was CiVi Biopharma founded?

    CiVi Biopharma was founded in 2017.

  • Where is CiVi Biopharma headquartered?

    CiVi Biopharma is headquartered in Chevy Chase, MD.

  • What is the size of CiVi Biopharma?

    CiVi Biopharma has 13 total employees.

  • What industry is CiVi Biopharma in?

    CiVi Biopharma’s primary industry is Drug Discovery.

  • Is CiVi Biopharma a private or public company?

    CiVi Biopharma is a Private company.

  • What is CiVi Biopharma’s current revenue?

    The current revenue for CiVi Biopharma is .

  • How much funding has CiVi Biopharma raised over time?

    CiVi Biopharma has raised $121M.

  • Who are CiVi Biopharma’s investors?

    RA Capital Management and Tang Capital Partners have invested in CiVi Biopharma.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process